Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis

Critical Reviews in Neurobiology

Volumn 10, Issue 3-4, 1996, Pages 371-394

  Herman, James P ^a   Prewitt, Chantal M F ^a   Cullinan, William E ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MARQUETTE UNIVERSITY   (United States)

Author keywords

Brainstem; Corticotropin releasing hormone; Gamma aminobutyric acid; Hippocampus; Hypothalamus; Paraventricular nucleus

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR;

AMYGDALOID NUCLEUS; BRAIN STEM; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; PREFRONTAL CORTEX; REVIEW; THALAMUS MIDLINE NUCLEUS;

EID: 0030463572     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v10.i3-4.50     Document Type: Review

References (206)

1. McEwen, B. S. and Stellar, E., Stress and the individual. Mechanisms leading to disease, Arch. Intern. Med., 153, 2093, 1993.
2. Kathol, R. G., Jaeckle, R. S. and Lopez, J. F., Pathophysiology of HPA axis abnormalities in patients with major depression: an update. Am. J. Psychiat., 146, 311, 1989.
3. Charney, D., Deutch, A. Y., Krystal, J. H., Southwick, S. M., and Davis, M., Psychobiologic mechanisms of posttraumatic stress disorder, Arch. Gen. Psychiat., 50, 295, 1993.
4. McEwen, B., Re-examination of the glucocorticoid hypothesis of stress and aging, Prog. Brain Res., 93, 365, 1992.
5. Landfield, P. W. and Eldridge, J. C., The glucocorticoid hypothesis of brain aging and neurodegeneration: recent modifications, Acta Endocrinol., 125, 54, 1991.
6. Sapolsky, R. M., Krey, L. C,. and McEwen, B. S., The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis, Endocrine Rev., 7, 284, 1986.
7. Landfield, P. W., Thibault, O., Mazzanti, M. L., Porter, N. M., and Kerr, D. S., Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis, J. Neurobiol., 23, 1247, 1992.
8. Yamamoto, K. R., Steroid receptor regulated transcription of specific genes and gene networks, Ann. Rev. Genetics, 19, 205, 1985.
9. Drouin, J., Sun, Y. L., Tremblay, S., Lavender, P., Schmidt, T. J., deLean, A., and Nemer, M., Homodimer formation is rate limiting for high affinity binding by the glucocorticoid receptor, Mol. Endocrinol, 6, 1299, 1992.
10. Herman, J. P., Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system, Cell. Mol. Neurobiol., 13, 349, 1993.
11. Munck, A., Guyre, P. M., and Holbrook, N. J., Physiological functions of glucocorticoids in stress and their relations to pharmacological actions, Endocrine Rev., 5, 25, 1984.
12. Antoni, F. A., Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor, Endocrine Rev., 7, 351, 1986.
13. Whitnall, M. H., Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system, Prog. Neurobiol., 40, 573, 1993.
14. Jones, M. T. and Gillham, B., Factors involved in the regulation of adrenocorticotropic hormone/ß-lipotropic hormones, Physiol. Rev., 68, 743, 1988.
15. Keller-Wood, M. and Dallman, M. F., Corticosteroid inhibition of ACTH secretion, Endocrine Rev., 5, 1, 1984.
16. Levin, N., Shinsako, J., and Dallman, M. F., Corticosterone acts on the brain to inhibit adrenalectomy-induced adrenocorticotropin secretion, Endocrinology, 122, 694, 1988.
17. Saphier, D. and Feldman, S., Iontophoresis of cortisol inhibits responses of identified paraventricular nucleus neurones to sciatic nerve stimulation, Brain Res., 535, 159, 1990.
18. Orchinik, M., Moore, F. L., and Rose, J. D., Mechanistic and functional studies of rapid corticosteroid actions, Ann. N.Y. Acad. Sci., 746, 101, 1994.
19. Dallman, M. F., Akana, S. F., Cascio, C. S., Darlington, D. N., Jacobson, L., and Levin, N., Regulation of ACTH secretion: variations on a theme of B, Recent Prog. Horm. Res., 43, 113, 1987.
20. Reul, J. M., van den Bosch, F. R., and deKloet, E. R., Differential response of type I and type II corticosteroid receptors to changes in plasma steroid level and circadian rhythmicity, Neuroendocrinol., 45, 407, 1987.
21. Reul, J. M. and deKloet, E. R., Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation, Endocrinology, 117, 2505, 1985.
22. Evans, R. M. and Arriza, J. L., A molecular framework for the actions of glucocorticoid hormones in the nervous system, Neuron, 2, 1105, 1989.
23. Joels, M. and deKloet, E. R., Control of neuronal excitability by corticosteroid hormones, Trend in Neurosci., 15, 25, 1992.
24. Morgan, J. I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the induceable proto-oncogenes fos and jun, Ann. Rev. Neurosci., 14, 421, 1991.
25. Plotsky, P. M., Cunningham, E. T., Jr., and Widmaier, E. P., Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion, Endocrine Rev., 10, 437, 1989.
26. Liu, J. P., Clarke, I. J., Funder, J. W., and Engler, D., Evidence that the central noradrenergic and adrenergic pathways activate the hypothalamic-pituitary-adrenal axis in the sheep, Endocrinology, 129, 200, 1991.
27. Radant, A., Peskind, E. R., Wilkinson, C. W., Veith, R. C., Dorsa, D. M., Leake, R. D., Ervin, M. G., and Raskind, M. A., Neurohypophyseal and pituitary-adrenocortical responses to the alpha 1 agonist methoxamine in humans, Neuroendocrinol., 55, 361, 1992.
28. Szafarczyk, A., Malaval, F., Laurent, A., Gibaud, R., and Assenmacher, I., Further evidence for a central stimulatory actions of catecholamines on adrenocorticotropin release in the rat, Endocrinology, 121, 883, 1987.
29. Plotsky, P. M., Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection, Endocrinology, 121, 924, 1987.
30. Guillaume, V., Conte-Devolx, B., Szararczyk, A., Malaval, F., Pares-Herbute, N., Grino, M., Alonso, G., Assenmacher, I., and Oliver, C., The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines, Neuroendocrinol., 46, 143, 1987.
31. Kiss, A. and Aguilera, G., Participation of alpha 1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress, Neuroendocrinol., 56, 153, 1992.
32. Saphier, D. and Feldman, S., Adrenoceptor specificity in the central regulation of adrenocortical secretion, Neuroscience, 28, 1231, 1989.
33. Guillaume, V., Conte, D. B., Magnan, E., Boudouresque, F., Grino, M., Cataldi, M., Muret, L., Priou, A., Figaroli, J. C., and Oliver, C., Effect of chronic active immunization with antiarginine vasopressin on pituitary-adrenal function in sheep, Endocrinology, 130, 3007, 1992.
34. Thrivikraman, K. V., Bereiter, D. A., and Gann, D. S., Catecholamine activity in paraventricular hypothalamus after hemorrhage in cats, Am. J. Physiol., 257, R370, 1989.
35. Szafarczyk, A., Alonso, G., Ixart, G., Malaval, F., and Assenmacher, I., Diurnal-stimulated and stress-induced ACTH release in rats is mediated by ventral noradrenergic bundle, Am. J. Physiol., 249, E219, 1985.
36. Sawchenko, P. E., Effects of catecholamine-depleting medullary knife cuts on corticotropin-releasing factor and vasopressin immunoreactivity in the hypothalamus of normal and steroid-manipulated rats, Neuroendocrinol., 48, 459, 1988.
37. Alonso, G., Szafarczyk, A., Balmefrezol, M. and Assenmacher, I., Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats, Brain Res., 397, 297, 1986.
38. Harbuz, M. S., Chowdrey, H. S., Jessop, D. S., Biswas, S., and Lightman, S. L., Role of catecholamines in mediating messenger RNA and hormonal responses to stress, Brain Res., 551, 52, 1991.
39. Cunningham, E. T., Jr. and Sawchenko, P. E., Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus, J. Comp. Neurol., 274, 60, 1988.
40. Cunningham, E. T., Jr., Bohn, M. C., and Sawchenko, P. E., Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat, J. Comp. Neurol., 292, 651, 1990.
41. Lightman, S. L. and Young III, W. S., Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat, J. Physiol. (Lond.), 394, 23, 1987.
42. Saphier, D. and Feldman, S., Catecholaminergic projections to tuberoinfundibular neurones of the paraventricular nucleus: III. Effects of adrenoceptor agonists and antagonists, Brain Res. Bull., 26, 863, 1991.
43. Ceccatelli, S., Vilar, M. J., Goldstein, M., and Hokfelt, T., Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress, Proc. Natl. Acad. Sci. U.S.A., 89, 9569, 1989.
44. Pezzone, M. A., Lee, W.-S., Hoffman, G. E., Pezzone, K. M., and Rabin, B. S., Activation of brainstem catecholaminergic neurons by conditioned and unconditioned aversive stimuli as revealed by c-Fos immunoreactivity, Brain Res., 608, 310, 1993.
45. Cullinan, W. E., Herman, J. P., Battaglia, D. F., Akil, H., and Watson, S. J., Pattern and time course of immediate early gene expression in rat brain following acute stress, Neurosci., 64, 477, 1995.
46. Hokfelt, T., Millhorn, D., Seroogy, K., Tsuruo, Y., Ceccatelli, S., Lindh, B., Meister, B., Melander, T., Schalling, M., Bartfai, T., and Terenius, L., Coexistence of peptides with classical transmitters, Experientia, 43, 768, 1987.
47. Sawchenko, P. E. and Swanson, L. W., The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat, J. Comp. Neurol., 218, 121, 1983.
48. Sawchenko, P. E., Benoit, R., and Brown, M. R., Somatostatin 28-immunoreactive inputs to the paraventricular and supraoptic nuclei: principal origin from non-aminergic neurons in the nucleus of the solitary tract, J. Chem. Neuroanat., 1, 81, 1988.
49. Sawchenko, P. E., Arias, C., and Bittencourt, J. C., Inhibin beta, somatostatin and enkephalin immunoreactivities coexist in caudal medullary neurons that project to the paraventricular nucleus of the hypothalamus, J. Comp. Neurol., 291, 269, 1990.
50. Gann, D. S., Ward, D. G., Baertschi, A. J., Carlson, D. E., and Maran, J. W., Neural control of ACTH release in response to hemorrhage, Ann. N.Y. Acad. Sci., 297, 477, 1977.
51. Chan, R. K. W., Brown, E. R., Ericsson, A., Kovacs, K. J., and Sawchenko, P. E., A comparison of two immediate-early genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry, J. Neurosci., 13, 5125, 1993.
52. Abercrombie, E. D. and Jacobs, B. L., Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli, J. Neurosci., 7, 2837, 1987.
53. Valentine, R. J., Page, M. E., and Curtis, A. L., Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor, Brain Res., 555, 25, 1991.
54. Smith, M. A., Brady, L. S., Glowa, J., Gold, P. W., and Herkenham, M., Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in locus coeruleus by in situ hybridization, Brain Res., 544, 26, 1991.
55. Lachuer, J., Gaillet, S., Barbagli, B., Buda, M., and Tappaz, M., Differential early time course activation of the brainstem catecholaminergic groups in response to various stresses, Neuroendocrinol., 53, 589, 1991.
56. Mamalaki, E., Kvetnansky, R., Brady, L. S., Gold, P. W., and Herkenham, M., Repeated immobilization stress alters tyrosine hydroxylase, corticotropin-releasing hormone and corticosteroid receptor ribonucleic acid levels in rat brain, J. Neuroendocrinol., 4, 689, 1993.
57. Amaral, D. G. and Sinnamon, H. M., The locus coeruleus: neuroanatomy of a central noradrenergic nucleus, Prog. Neurobiol., 9, 147, 1977.
58. Nakane, H., Shimizu, N., and Hori, T., Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis, Am. J. Physiol., 257, R1559, 1994.
59. Nisenbaum, L. K. and Abercrombie, E. D., Presynaptic alterations associated with enhancement of evoked release and synthesis of norepinephrine in hippocampus of chronically cold-stressed rats, Brain Res., 608, 280, 1993.
60. Yau, J. L. W. and Seckl, J. R., Central 6-hydroxydopamine lesions decrease mineralocorticoid, but not glucocorticoid receptor gene expression in the rat hippocampus, Neurosci. Lett., 142, 159, 1992.
61. Saphier, D. and Feldman, S., Paraventricular nucleus neuronal responses following electrical stimulation of the midbrain dorsal raphe: evidence for cotransmission, Exp. Brain Res., 78, 407, 1989.
62. Feldman, S., Conforti, N., and Melamed, E., Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion, Brain Res. Bull., 18, 165, 1987.
63. Feldman, S. and Weidenfeld, J., Depletion of hypothalamic norepinephrine and serotonin enhances the dexamethasone negative feedback effect on adrenocortical secretion, Psychoneuroendocrinol., 16, 397, 1991.
64. Korte, S. M., Van, D. S., Bouws, G. A., Koolhaas, J. M., and Bohus, B., Involvement of hypothalamic serotonin in activation of the sympatho-adrenomedullary system and hypothalamo-pituitary-adrenocortical axis in male Wistar rats, Eur. J. Pharmacol., 197, 225, 1991.
65. Welch, J. E., Farrar, G. E., Dunn, A. J., and Saphier, D., Central 5-HT1A receptors inhibit adrenocortical secretion, Neuroendocrinol., 57, 272, 1993.
66. Sawchenko, P. E., Swanson, L. W., Steinbusch, H. W., and Verhofstad, A. A., The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat, Brain Res., 277, 355, 1983.
67. Sapolsky, R. M., Rivier, C., Yamamoto, G., Plotsky, P., and Vale, W., Interleukin-1 stimulates secretion of the hypothalamic corticotropin-releasing factor, Science, 238, 522, 1987.
68. Berkenbosh, F., van Oers, J., del Rey, A., Tilders, F., and Besedovsky, H., Corticotropin-releasing factor-producing neurons in the rat are activated by interleukin-1, Science, 238, 524, 1987.
69. Ericsson, A., Kovacs, K. J., and Sawchenko, P. E., A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons, J. Neurosci., 14, 897, 1994.
70. Harding, J. W., Stone, L. P., and Wright, J. W., The distribution of angiotensin II binding sites in the rodent brain, Brain Res., 205, 265, 1981.
71. Saavedra, J. M. and Kurihara, M., Autoradiography of atrial natriuretic peptide (ANP) receptors in the rat brain, Can. J. Physiol. Pharmacol., 69, 1567, 1991.
72. Plotsky, P. M., Sutton, S. W., Bruhn, T. O., and Ferguson, A. V., Analysis of the role of angiotensin II in mediation of adrenocorticotropin secretion, Endocrinology, 122, 538, 1988.
73. Lind, R. W., Swanson, L. W., and Ganten, D., Angiotensin II immunoreactive pathways in the central nervous system of the rat: evidence for a projection from the subfornical organ to the paraventricular nucleus of the hypothalamus, Clin. Exp. Hypertension [A], 6, 1915, 1984.
74. Uht, R. M., McKelvy, J. F., Harrison, R. W., and Bohn, M. C., Demonstration of glucocorticoid receptor-like immunoreactivity in glucocorticoid-sensitive vasopressin and corticotropin-releasing factor neurons in the hypothalamic paraventricular nucleus, J. Neurosci. Res., 19, 405, 1988.
75. Sawchenko, P. E., Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus, Brain Res., 403, 213, 1987.
76. Kovacs, K., Kiss, J. Z., and Makara, G. B., Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy, Neuroendocrinol., 44, 229, 1986.
77. Makino, S., Smith, M. A., and Gold, P. W., Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels, Endocrinology, 136, 3299, 1995.
78. Herman, J. P., Adams, D., and Prewitt, C. M., Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm, Neuroendocrinol., 61, 180, 1995.
79. Herman, J. P., Wiegand, S. J., and Watson, S. J., Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations, Endocrinology, 127, 2408, 1990.
80. Dallman, M. F., Levin, N., Cascio, C. S., Akana, S. F., Jacobson, L., and Kuhn, R. W., Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors, Endocrinology, 124, 2844, 1989.
81. Bradbury, M. J., Akana, S. F., and Dallman, M. F., Roles of type I and type II corticosteroid receptors in regulation of basal activity in the HPA axis during the diurnal trough and the peak: Evidence for a non-additive effect of combined receptor occupation, Endocrinology, 134, 1286, 1994.
82. Reul, J. M. and deKloet, E. R., Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis, J. Steroid Biochem., 24, 269, 1986.
83. Arriza, J. L., Simerly, R. B., Swanson, L. W., and Evans, R. M., Neuronal mineralocorticoid receptor as a mediator of glucocorticoid response, Neuron, 1988; 1, 887, 1988.
84. Ahima, R. S., Krozowski, Z., and Harlan, R. E., Type I corticosteroid receptor-like immunoreactivity in the rat CNS: distribution and regulation by corticosteroids, J. Comp. Neurol, 313, 522, 1991.
85. Jacobson, L. and Sapolsky, R. M., The role of the hippocampus in feedback regulation of the hypothalamo-pituitary-adrenocortical axis, Endocrine Rev., 12, 118, 1991.
86. Knigge, K. M., Adrenocortical response to stress in rats with lesions in hippocampus and amygdala, Proc. Soc. Exp. Biol. Med., 108, 18, 1961.
87. Knigge, K. M. and Hays, M., Evidence of inhibitive role of hippocampus in neural regulation of ACTH release, Proc. Soc. Exp. Biol. Med., 114, 67, 1963.
88. Fendler, K., Karmos, G., and Telegdy, G., The effect of hippocampal lesion on pituitary-adrenal function, Acta Physiol. Scand., 20, 293, 1961.
89. Slusher, M. A. and Hyde, J. E., Effect of limbic stimulation on release of corticosteroids into the adrenal venous effluent of the cat, Endocrinology, 60, 1080, 1961.
90. Rubin, R. T., Mandell, A. J., and Crandall, P. H., Corticosteroid responses to limbic stimulation in man: localization of stimulation sites, Science, 153, 1212, 1966.
91. Dunn, J. D. and Orr, S. E., Differential plasma corticosterone responses to hippocampal stimulation, Exp. Brain Res., 54, 1, 1984.
92. Feldman, S. and Confronti, N., Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity, Neuroendocrinol., 30, 52, 1980.
93. Magarinos, A. M., Somoza, G., and DeNicola, A. F., Glucocorticoid negative feedback and glucocorticoid receptors after hippocampectomy in rats, Horm. Metab. Res., 19, 105, 1987.
94. Sapolsky, R. M., Zola-Morgan, S., and Squire, L. R., Inhibition of glucocorticoid secretion by the hippocampal formation in the primate, J. Neurosci., 11, 3695, 1991.
95. Sapolsky, R. M., Krey, L. C., and McEwen, B. S., Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response, Proc. Natl. Acad. Sci. U.S.A., 81, 6174, 1984.
96. Sapolsky, R. M., Armanini, M. P., Sutton, S. W., and Plotsky, P. M., Elevation of hypophysial portal concentrations of adrenocorticotropin secretagogues after fornix transection, Endocrinology, 125, 2881, 1989.
97. Herman, J. P., Cullinan, W. E., Young, E. A., Akil, H., and Watson, S. J., Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus CRH and AVP mRNA expression, Brain Res., 592, 228, 1992.
98. Herman, J. P., Schäfer, M. K.-H., Young, E. A., Thompson, R., Douglass, J., Akil, H., and Watson, S. J., Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis, J. Neurosci., 9, 3072, 1989.
99. Cullinan, W. E., Herman, J. P., and Watson, S. J., Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J. Comp. Neurol., 332, 1, 1993.
100. Lanier, J. P., Van Hartesveldt, C., Weis, B., and Isaacson, R. L., Effects of differential hippocampal damage upon rhythmic and stress-induced corticosterone secretion in the rat, Neuroendocrinol., 18, 154, 1975.
101. Iuvone, P. M. and Van Hartesveldt, C., Locomotor activity and plasma corticosterone in rats with hippocampal lesions, Behav. Biol., 16, 515, 1976.
102. Bradbury, M. J., Strack, A. M., and Dallman, M. F., Lesions of the hippocampal efferent pathway (fimbria-fornix) do not alter sensitivity of adrenocorticotropin to feedback inhibition by corticosterone in rats, Neuroendocrinol., 58, 396, 1993.
103. Herman, J. P., Dolgas, C. M., and Carlson, S. L., Behavioral, neuroendocrine and neuroimmune analysis of hippocampal stress integration, Soc. Neurosci. Abs., 20, 940, 1994.
104. Herman, J. P., Cullinan, W. E., Morano, M. I., Akil, H., and Watson, S. J., Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis, J. Neuroendocrinol., 7, 475, 1995.
105. Diorio, D., Viau, V., and Meaney, M. J., The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamo-pituitary-adrenal responses to stress, J. Neurosci., 13, 3839, 1993.
106. Feldman, S. and Conforti, N., Amygdalectomy Inhibits adrenocortical responses to somatosensory and olfactory stimulation, Neuroendocrinol., 32, 330, 1981.
107. Allen, J. P. and Allen, C. F., Role of the amygdaloid complexes in the stress-induced release of ACTH in the rat, Neuroendocrinol., 15, 220, 1974.
108. Allen, J. P. and Allen, C. F., Amygdalar participation in tonic ACTH secretion in the rat, Neuroendocrinol., 19, 115, 1975.
109. Beaulieu, S., DiPaolo, T., and Barden, N., Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotonergic system and its relevance to the glucocorticoid delayed negative feedback mechanism, Neuroendocrinol., 44, 247, 1986.
110. Feldman, S., Conforti, N., Itzik, A., and Weidenfeld, J., Differential effect of amygdaloid lesions of CRF-41, ACTH and corticosterone responses following neural stimuli, Brain Res., 658, 21, 1994.
111. Van de Kar, L. D., Piechowski, R. A., Rittenhouse, P. A., and Gray, T. A., Amygdaloid lesions: differential effect on conditioned stress and immobilization-induced increases in corticosterone and renin secretion, Neuroendocrinol., 54, 89, 19915.
112. Davis, M., The role of the amygdala in fear and anxiety, Ann. Rev. Neurosci., 15, 353, 1992.
113. Feldman, S., Conforti, N., and Saphier, D., The preoptic area and bed nucleus of the stria terminalis are involved in the effects of the amygdala on adrenocortical secretion, Neurosci., 37, 775, 1990.
114. Dunn, J. D. and Whitener, J., Plasma corticosterone responses to electrical stimulation of the amygdaloid complex: cytoarchitectonic specificity, Neuroendocrinol., 42, 211, 1986.
115. Gray, T. S., Carney, M. E., and Magnuson, D. J., Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: Possible role in stress-induced adrenocorticotropin release, Neuroendocrinol., 50, 433, 1989.
116. Prewitt, C. M. and Herman, J. P., Anatomical connections between the amygdaloid central nucleus and the paraventricular nucleus of the hypothalamus: a combined retrograde-anterograde tracing study, Soc. Neurosci. Abs., 21, 1389, 1995.
117. Price, J. L., Russchen, F. T., and Amaral, D. G., The limbic region. II. The amygdaloid complex, in Handbook of Chemical Neuroanatomy, Björklund, A., Hökfelt, T. and Swanson, L. W., Eds., Elsevier, Amsterdam, 1987, 279.
118. Casada, J. H. and Dafny, N., Restraint and stimulation of the bed nucleus of the stria terminalis produce similar stress-like behaviors, Brain Res. Bull., 27, 207, 1991.
119. Gray, T. S., Piechowski, R. A., Yracheta, J. M., Rittenhouse, P. A., Bethea, C. L., and Van de Kar, L. D., Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone, Neuroendocrinol., 57, 517, 1993.
120. Herman, J. P., Cullinan, W. E., and Watson, S. J., Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression, J. Neuroendocrinol., 6, 433, 1994.
121. Dunn, J. D., Plasma corticosterone responses to electrical stimulation of the bed nucleus of the stria terminalis, Brain Res., 407, 327, 1987.
122. Seggie, J., Uhlir, I., and Brown, G. M., Adrenal stress responses following septal lesions in the rat, Neuroendocrinol., 16, 225, 1974.
123. Dobrakovova, M., Kvetnansky, R., and Torda, T., Changes of plasma and adrenal catecholamines and corticosterone in stressed rats with septal lesions, Physiol. Behav., 29, 41, 1982.
124. Uhlir, I., Seggie, J., and Brown, G. M., The effect of septal lesions on the threshold of adrenal stress response, Neuroendocrinol., 14, 351, 1974.
125. Bouille, C. and Bayle, J. D., Influence of septal nuclei on basal pituitary-adrenocortical function in birds, Neuroendocrinol., 18, 281, 1975.
126. Usher, D. R., Lieblich, I., and Siegel, R. A., Pituitary-adrenal function after small and large lesions in the lateral septal area in food deprived rats, Neuroendocrinol., 16, 156, 1974.
127. Swanson, L. W., Köhler, C., and Björklund, A., The limbic region. I. The septohippocampal system, in Handbook of Chemical Neuroanatomy, Björklund, A., Hökfelt, T. and Swanson, L. W., Eds., Elsevier, Amsterdam, 1987, 125.
128. Swanson, L. W. and Sawchenko, P. E., Hypothalamic integration: organization of the para-ventricular and supraoptic nuclei, Ann. Rev. Neurosci., 6, 269, 1983.
129. Roland, B. L. and Sawchenko, P. E., Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus of the rat, J. Comp. Neurol., 332, 123, 1993.
130. Calogero, A. E., Galluci, W. T., Chrousos, G. P., and Gold, P. W., Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro, Brain Res., 463, 28, 1988.
131. Hillhouse, E. W. and Milton, N. G. N., Effect of noradrenaline and g-aminobutyric acid on the secretion of corticotropin-releasing factor-41 and arginine vasopressin form the rat hypothalamus in vitro, J. Endocrinol., 122, 719, 1989.
132. Makara, G. B. and Stark, E., Effect of gamma-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release, Neuroendocrinol., 16, 178, 1974.
133. King, B. M., Dallman, M. F., Esquerre, K. R., and Frohman, L. A., Radio-frequency vs. electrolytic VMH lesions: differential effects on plasma hormones, Am. J. Physiol., 254, R917, 1988.
134. Suemaru, S., Darlington, D. N., Akana, S. F., Cascio, C. S., and Dallman, M. F., Ventromedial hypothalamic lesions inhibit corticosteroid feedback regulation of basal ACTH during the trough of the circadian rhythm, Neuroendocrinol., 61, 453, 1995.
135. Dolnikoff, M. S., Kater, C. E., Egami, M., de Andrade, I. S., and Marmo, M. R., Neonatal treatment with monosodium glutamate increases plasma corticosterone in the rat, Neuroendocrinol., 48, 645, 1988.
136. Larsen, P. J., Mikkelsen, J. D., Jessop, D., Lightman, S. L., and Chowdrey, H. S., Neonatal monosodium glutamate treatment alters both the activity and the sensitivity of the rat hypothalamo-pituitary-adrenocortical axis, J. Endocrinol., 141, 497, 1994.
137. Magarinos, A. M., Estivariz, F., Morano, M. I., and de Nicola, A. F., Regulation of the central nervous system-pituitary-adrenal axis in rats after neonatal treatment with monosodium glutamate, Neuroendocrinol., 48, 105, 1988.
138. Plotsky, P. M., Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats, Regul. Pept., 16, 235, 1986.
139. Albers, H., Ottenweiler, J., Liou, S., Lumpkin, S., and Anderson, E., Neuropeptide Y in the hypothalamus: effect on corticosterone and single-unit activity, Am. J. Physiol., 258, R376, 1990.
140. Wahlestedt, C., Skagerberg, G., Ekman, R., Heilig, M., Sundler, F., and Hakanson, R., Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat, Brain Res., 417, 33, 1987.
141. Yang, G., Matocha, M. F., and Rapoport, S. I., Localization of glucocorticoid receptor ribonucleic acid in hippocampus of rat brain using in situ hybridization, Mol. Endocrinol., 2, 682, 1988.
142. Wong, D. L., Lesage, A., Siddall, B., and Funder, J. W., Glucocorticoid regulation of phenylethanolamine N-methyltransferase in vivo, FASEB J., 6, 3310, 1992.
143. Fink, G., Dow, R. C., Casley, D., Johnston, C. I., Bennie, J., Carroll, S., and Dick, H., Atrial natriuretic peptide is involved in the ACTH response to stress and glucocorticoid negative feedback in the rat, J. Endocrinol., 135, 37, 1992.
144. Dayanithi, G. and Antoni, F. A., Atriopeptins are potent inhibitors of ACTH secretion by rat anterior pituitary cells in vitro: involvement of the atrial natriuretic factor receptor domain of membrane-bound guanylyl cyclase, J. Endocrinol., 125, 39, 1990.
145. Antoni, F. A., Hunter, E. F., Lowry, P. J., Noble, J. M., and Seckl, J. R., Atriopeptin: an endogenous corticotropin-release inhibiting hormone, Endocrinology, 130, 1753, 1992.
146. Langub, M. C., Jr., Watson, R. E., Jr., and Herman, J. P., Distribution of atrial natriuretic peptide and C-type natriuretic peptide precursor mRNAs in the male rat brain, J. Comp. Neurol., 356, 183, 1995.
147. Charles, C. J., Richards, A. M., and Espiner, E. A., Central C-type natriuretic peptide but not atrial natriuretic factor lowers blood pressure and adrenocortical secretion in normal conscious sheep, Endocrinology, 131, 1721, 1992.
148. Baker, R. A. and Herkenham, M., Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: Neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat, J. Comp. Neurol., 358, 518, 1995.
149. Liposits, Z., Sievers, L., and Paull, W. K., Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic levels, Histochem., 88, 227, 1988.
150. Piekut, D. T., Interactions of immunostained ACTH1-39 fibers and CRF neurons in the paraventricular nucleus of rat hypothalamus: application of avidin-glucose oxidase to dual immunostaining procedures, J. Histochem. Cytochem., 1987; 35, 261, 1987.
151. Okamura, H., Abitbol, M., Julien, J. F., Dumas, S., Berod, A., Geffard, M., Kitahama, K., Bobillier, P., Mallet, J., and Wiklund, L., Neurons containing messenger RNA encoding glutamate decarboxylase in rat hypothalamus demonstrated by in situ hybridization, with special emphasis on cell groups in medial preoptic area, anterior hypothalamic area and dorsomedial hypothalamic nucleus, Neurosci., 39, 675, 1990.
152. Shekhar, A. and Katner, J. S., Dorsomedial hypothalamic GABA regulates anxiety in the social interaction test, Pharmacol. Biochem. Behav., 50, 253, 1995.
153. Inglefield, J. R., Schwarzkopf, S. B., and Kellogg, C. K., Alterations in behavioral responses to stressors following excitotoxin lesions of dorsomedial hypothalamic regions, Brain Res., 633, 151, 1994.
154. Cullinan, W. E., Helmreich, D., and Watson, S. J., Fos expression in forebrain afferents to the hypothalamic paraventricular nucleus following swim stress, J. Comp. Neurol., 1996, in press.
155. Bellinger, L. L., Bernardis, L. L., McCusker, R. H., and Campion, D. R., Plasma hormone levels in growth-retarded rats with dorsomedial hypothalamic lesions, Physiol. Behav., 34, 783, 1985.
156. Saphier, D. and Feldman, S., Effects of stimulation of the preoptic area on hypothalamic paraventricular nucleus unit activity and corticosterone secretion in freely moving rats, Neuroendocrinol., 42, 167, 1986.
157. Feldman, S. and Conforti, N., The role of the medial septal nucleus in mediating adrenocortical responses to somatosensory stimulation, J. Neurosci. Res., 5, 19, 1980.
158. Rice, R. W., Abe, K., and Critchlow, V., Abolition of plasma growth hormone response to stress and of the circadian rhythm in pituitary-adrenal function in female rats with preoptic-anterior hypothalamic lesions, Brain Res., 148, 129, 1978.
159. Bealer, S. L. and Schneider, E. G., Plasma corticosterone and volume after preoptic recess lesions and volume depletion, Am. J. Physiol., 248, R161, 1985.
160. Viau, V. and Meaney, M. J., The inhibitory effect of testosterone on hypothalamo-pituitary-adrenal responses to stress is mediated by the medial preoptic area, J. Neurosci., 16, 1866, 1996.
161. Mugnaini, E. and Oertel, W. H., An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry, in GABA and Neuropeptides in the CNS, Vol. 1, Björklund, A., Hökfelt, T., Eds., Elsevier, Amsterdam, 1985, 436.
162. Ryan, M. C. and Gundlach, A. L., Anatomical localisation of preproatrial natriuretic peptide in the rat brain by in situ hybridization histochemistry: Novel identification in olfactory regions, J. Comp. Neurol., 356, 168, 1995.
163. Langub, M. C., Jr., Watson, R. E., Jr., and Herman, J. P., Distribution of atrial natriuretic peptide and C-type natriuretic peptide precursor mRNAs in the male rat brain, J. Comp. Neurol., 356, 183, 1995.
164. Cascio, C. S., Shinsako, J., and Dallman, M. F., The suprachiasmatic nuclei stimulate evening ACTH secretion in the rat, Brain Res., 423, 173, 1987.
165. Watts, A. G., Swanson, L. W., and Sanchez-Watts, G., Efferent projections of the suprachiasmatic nucleus: Studies using anterograde transport of phaseolus vulgaris-leucoagglutinin in the rat, J. Comp. Neurol., 258, 204, 1987.
166. Buijs, R. M., Markman, M., Nunes, C. B., Hou, Y. X., and Shinn, S., Projections of the suprachiasmatic nucleus to stress-related areas in the rat hypothalamus: a light and electron microscopic study, J. Comp. Neurol., 335, 42, 1993.
167. ter Horst, G. J. and Luiten, P. G. M., Phaseolus vulgaris leuco-agglutinin tracing of intrahypothalamic connections of the lateral, ventromedial, dorsomedial and paraventricular hypothalamic nuclei in the rat, Brain Res. Bull., 18, 191, 1987.
168. Buijs, R. M., Kalsbeek, A., van der Woude, T. P., van Heerikhuize, J. J., and Shinn, S., Suprachiasmatic nucleus lesion increases corticosterone secretion, Am. J. Physiol., 264, R1186, 1993.
169. Kalsbeek, A., Buijs, R. M., van Heerikhuize, J., Arts, M., and van der Woude, T. P., Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release, Brain Res., 580, 62, 1992.
170. Tsagarakis, S., Rees, L. H., Besser, G. M., and Grossman, A., Opiate peptide receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro, Neuroendocrinol., 51, 599, 1990.
171. Mansour, A. M., Fox, C. A., Burke, S., Meng, F., Thompson, R. C., Akil, H., and Watson, S. J., Mu, delta and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study, J. Comp. Neurol., 350, 412, 1994.
172. Mansour, A. M., Fox, C. A., Meng, F., Akil, H., and Watson, S. J., Kappa1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA, Mol. Cell. Neurosci., 5, 124, 1994.
173. Harlan, R. E., Shivers, B. D., Romano, G. J., Howells, R. D., and Pfaff, D. W., Localization of proenkephalin mRNA in the rat brain and spinal cord by in situ hybridization, J. Comp. Neurol., 258, 159, 1987.
174. Baker, B. I., Bird, D. J., and Buckingham, J. C., Salmonid melanin-concentrating hormone inhibits corticotropin release, J. Endocrinol., 106, R5, 1985.
175. Bittencourt, J. C., Presse, F., Arias, C., Peto, C., Vaughan, J., Nahon, J. L., Vale, W., and Sawchenko, P. E., The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization, J. Comp. Neurol., 319, 218, 1992.
176. Presse, F., Hervieu, G., Imaki, T., Sawchenko, P. E., Vale, W., and Nahon, J.-L., Rat melanin-concentrating hormone messenger RNA expression: Marked changes during development and after stress and glucocorticoid stimuli, Endocrinology, 131, 1241, 1992.
177. Larsen, P. J., Jessop, D., Patel, H., Lightman, S. L., and Chowdrey, H. S., Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus, J. Neuroendocrinol., 5, 99, 1993.
178. Faria, M., Navarra, P., Tsagaraskis, S., Besser, G. M., and Grossman, A. B., Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro, Brain Res., 538, 76, 1991.
179. Bittencourt, J. C., Benoit, R., and Sawchenko, P. E., Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: partial overlap with ascending catecholaminergic projections, J. Chem. Neuroanat., 4, 63, 1991.
180. Johansson, O., Hokfelt, T., and Elde, R. P., Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat, Neurosci., 13, 265, 1984.
181. Serby, M., Richardson, S. B., Rypma, B., Twente, S., and Potrosen, J. P., Somatostatin regulation of the CRF-ACTH-cortisol axis, Biol. Psychiat., 21, 971, 1986.
182. Litvin, Y., Leiser, M., Fleischer, N., and Erlichman, J., Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3′,5′-monophosphate-dependent protein kinase isoenzymes in AtT20 cells, Endocrinology, 119, 737, 1986.
183. Tempel, D. L. and Leibowitz, S. F., Galanin inhibits insulin and corticosterone release after injection into the PVN, Brain Res., 536, 353, 1990.
184. Hooi, S. C., Maiter, D. M., Martin, J. B., and Koenig, J. I., Galaninergic mechanisms are involved in the regulation of corticotropin and thyrotropin secretion in the rat, Endocrinology, 127, 2281, 1990.
185. Ceccatelli, S., Eriksson, M., and Hokfelt, T., Distribution and coexistence of corticotropin-releasing factor, neurotensin-, enkephalin-, cholecystokinin-, galanin-, and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus, Neuroendocrinol., 49, 309, 1989.
186. Kamilaris, T. C., Johnson, E. O., Calogero, A. E., Kalogeras, K. T., Bernardini, R., Chrousos, G. P., and Gold, P. W., Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone, Endocrinology, 130, 1764, 1992.
187. Biro, E., Sarnyai, Z., Penke, B., Szabo, G., and Telegdy, G., Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats, Neuroendocrinol., 57, 340, 1993.
188. Micevych, P. E., Park, S. S., Akesson, T. R., and Elde, R., Distribution of cholecystokinin-immunoreactive cell bodies in the male and female rat: I. Hypothalamus, J. Comp. Neurol., 255, 124, 1987.
189. Imaki, T., Shibasaki, T., Hotta, M., and Demura, H., Intracerebroventricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress, Brain Res., 616, 114, 1993.
190. Silverman, A. J., Hou-Yu, A., and Chen, W. P., Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus, Neuroendocrinol., 49, 290, 1989.
191. Luo, X., Kiss, A., Makara, G., Lolait, S. J., and Aguilera, G., Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat, J. Neuroendo., 6, 689, 1994.
192. Makino, S., Schulkin, J., Smith, M. A., Pacak, K., Palkovits, M., and Gold, P. W., Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress, Endoocrinology, 136, 4517, 1995.
193. Dallman, M. F., Strack, A. M., Akana, S. F., Bradbury, M. J., Hanson, E. S., Scribner, K. A., and Smith, M., Feast and famine: critical role of glucocorticoids with insulin in daily energy flow, Front. Neuroendocrinol., 14, 303, 1993.
194. Viau, V. and Meaney, M. J., Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat, Endocrinology, 129, 2503, 1991.
195. Carey, M. P., Deterd, C. H., de Koning, J., Helmerhorst, F., and de Kloet, E. R., The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat, J. Endocrinol., 144, 311, 1995.
196. Handa, R. J., Burgess, L. H., Kerr, J. E., and O'Keefe, J. A., Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis, Horm. Behav., 28, 464, 1994.
197. Raff, H., Glucocorticoid inhibition of neurohypohysial vasopressin, Am. J. Physiol., 252, R635, 1987.
198. Grunfield, J. P., Glucocorticoids in blood pressure regulation, Horm. Res., 34, 111, 1990.
199. Whitworth, J. A., Brown, M. A., Kelly, J. J., and Williamson, P. M., Experimental studies on cortisol-induced hypertension in humans, J. Hum. Hypertens., 9, 395, 1995.
200. Briski, K. P., Effects of peripheral versus central administration of the endogenous glucocorticoid, corticosterone, and the glucocorticoid agonist, RU 28362, on LH release in male rats, Brain Res., 670, 66, 1995.
201. Sawchenko, P. E., Brown, E. R., Chan, R. W. K., Ericsson, A., Li, H.-Y., Roland, B. K., and Kovacs, K. J., The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress, Prog. Brain Res., 1996, in press.
202. Gaillet, S., Lachuer, J., Malaval, F., Assenmacher, I., and Szafarczyk, A., The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors, Exp. Brain Res., 87, 173, 1991.
203. Li, H.-Y., Ericsson, A., and Sawchenko, P. E., Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms, Proc. Natl. Acad. Sci. U.S.A., 93, 2359, 1996.
204. Decavel, C. and Van Den Pol, A. N., GABA: A dominant neurotransmitter in the hypothalamus, J. Comp. Neurol., 302, 1019, 1990.
205. Dallman, M. F., Stress update: Adaptation of the hypothalamo-pituitary-adrenal axis to chronic stress, Trends. Endocrinol. Metab., 4, 62, 1993.
206. Bradbury, M. J., Cascio, C. S., Scribner, K. A., and Dallman, M. F., Stress-induced adrenocorticotropin secretion: diurnal responses and decreases during stress in the evening are not dependent on corticosterone, Endocrinology, 128, 680, 1991.